2019
DOI: 10.1093/ejcts/ezy487
|View full text |Cite
|
Sign up to set email alerts
|

Tricuspid valve relocation with endomyocardial fibrosis removal for Löeffler’s endocarditis

Abstract: Löffler endocarditis with hypereosinophilic syndrome is rare but can cause critical ventricular obliteration by endomyocardial fibrosis. A 52-year-old woman experienced severe right heart failure with extreme shrinkage of her right ventricle, severe tricuspid regurgitation and marked right atrial enlargement. Preoperative tests showed identical pressures in the right atrium and pulmonary artery. Endocardial stripping was done, and to enlarge the right ventricle, we relocated the anterior and posterior tricuspi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…In some cases, timely emergency surgical intervention may be necessary, particularly when patients experience cardiac valve dysfunction, dramatic decreased cardiac output and obstruction. 10 , 11 In this case, the patient underwent emergency surgery, coupled with corticosteroid therapy, which led to a positive prognosis during the 3 months follow-up. This case highlights the effectiveness of timely surgical intervention combined with corticosteroid therapy in selected patients.…”
Section: Discussionmentioning
confidence: 81%
“…In some cases, timely emergency surgical intervention may be necessary, particularly when patients experience cardiac valve dysfunction, dramatic decreased cardiac output and obstruction. 10 , 11 In this case, the patient underwent emergency surgery, coupled with corticosteroid therapy, which led to a positive prognosis during the 3 months follow-up. This case highlights the effectiveness of timely surgical intervention combined with corticosteroid therapy in selected patients.…”
Section: Discussionmentioning
confidence: 81%
“…The other methods of surgical treatment reported in patients with CMP are intracardiac assist device implantation and heart transplantation, with 87%, 81%, and 74% survival at 1, 3, and 5 years, respectively [ 27 ]. The use of these methods is limited by their inaccessibility and existence of specific complications [ 28 , 29 ].…”
Section: Discussionmentioning
confidence: 99%